Sareum Holdings

Sareum Holdings

Broadcast on: January 25, 2022
Duration: 9:50

Sareum is a UK-based drug development company, specialising in small molecule kinase inhibitors.

  • CEO

    Dr Tim Mitchell, CEO, Sareum

    Dr Tim Mitchell is CEO of drug discovery company, Sareum, which he co-founded in 2003 and floated on the AIM market of the London Stock Exchange in 2004. Tim has a wide breadth of management, business and research expertise gained over 30 years in biotech, large pharmaceutical and research service companies. Prior to co-founding Sareum, he was Director of Structure-Based Discovery at Millennium Pharmaceuticals, Director of Computational Chemistry at Cambridge Discovery Chemistry, and Team Leader at SmithKline Beecham Pharmaceuticals. Tim has a PhD in Computational Chemistry and a BSc in Chemistry.

More from OETV

What's happening on OETV

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

X

We value your privacy

This website or its third party tools uses cookies, which are necessary for its functioning and required to achieve the purpose illustrated in our Privacy Policy. By clicking "Accept" or dismissing this notice, you agree to our website's use of cookies.